Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t(15;17)(q22;q12)/PML-RARA.

Literature DB >> 29237593

Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t(15;17)(q22;q12)/PML-RARA.

Li Yao¹, Lijun Wen¹, Nana Wang¹, Tianhui Liu², Yang Xu^1,2, Changgeng Ruan¹, Depei Wu^1,2, Suning Chen^1,2.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2017 PMID： 29237593 DOI： 10.1182/blood-2017-09-807370

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions.

Authors: Lijun Wen; Yang Xu; Li Yao; Nana Wang; Qinrong Wang; Tianhui Liu; Jinlan Pan; Jiannong Cen; Huifeng Zhou; Miao Miao; Yang W Shao; Xiaonan Wang; Xiaoxia Wang; Changgeng Ruan; Depei Wu; Suning Chen
Journal: Haematologica Date: 2018-09-20 Impact factor: 9.941

Review 2. Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

Authors: Xiang Zhang; Jiewen Sun; Wenjuan Yu; Jie Jin
Journal: Biomark Res Date: 2021-05-06

3. Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.

Authors: Ayush Sharma; Naoki Oishi; Rebecca L Boddicker; Guangzhen Hu; Hailey K Benson; Rhett P Ketterling; Patricia T Greipp; Darlene L Knutson; Sara M Kloft-Nelson; Rong He; Bruce W Eckloff; Jin Jen; Asha A Nair; Jaime I Davila; Surendra Dasari; Konstantinos N Lazaridis; N Nora Bennani; Tsung-Teh Wu; Grzegorz S Nowakowski; Joseph A Murray; Andrew L Feldman
Journal: Blood Date: 2018-03-28 Impact factor: 25.476

4. Arsenic trioxide induces proteasome dependent TBLR1-RARα degradation to improve leukemia eradication through cell differentiation enhancement.

Authors: Yirui Chen; Manning Li; Han Wu; Shijin Yuan; Yan Xia; Yingjian Wang; Ye Peng; Jianping Lan; Yanzhong Wang
Journal: J Cancer Date: 2022-04-18 Impact factor: 4.478

5. RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin-proteasome pathway contributes to the reversion of ATRA resistance.

Authors: Wenzhe Yan; Ji Li; Yang Zhang; Yafei Yin; Zhao Cheng; Jiayi Wang; Guoyu Hu; Sufang Liu; Yewei Wang; Yunxiao Xu; Hongling Peng; Guangsen Zhang
Journal: Cancer Cell Int Date: 2019-04-04 Impact factor: 5.722

6. A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review.

Authors: Yiping Liu; Fang Xu; Hong Hu; Jingjing Wen; Jing Su; Qiaolin Zhou; Wen Qu
Journal: Onco Targets Ther Date: 2019-08-02 Impact factor: 4.147

Review 7. PLZF-RAR_α, NPM1-RAR_α, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.

Authors: Marta Sobas; Maria Carme Talarn-Forcadell; David Martínez-Cuadrón; Lourdes Escoda; María J García-Pérez; Jose Mariz; María J Mela-Osorio; Isolda Fernández; Juan M Alonso-Domínguez; Javier Cornago-Navascués; Gabriela Rodríguez-Macias; María E Amutio; Carlos Rodríguez-Medina; Jordi Esteve; Agnieszka Sokół; Thais Murciano-Carrillo; María J Calasanz; Manuel Barrios; Eva Barragán; Miguel A Sanz; Pau Montesinos
Journal: Cancers (Basel) Date: 2020-05-21 Impact factor: 6.639

Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t(15;17)(q22;q12)/PML-RARA.

1. Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions.

Review 2. Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

3. Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.

4. Arsenic trioxide induces proteasome dependent TBLR1-RARα degradation to improve leukemia eradication through cell differentiation enhancement.

5. RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin-proteasome pathway contributes to the reversion of ATRA resistance.

6. A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review.

Review 7. PLZF-RAR_α, NPM1-RAR_α, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.

Review 8. Classic and Variants APLs, as Viewed from a Therapy Response.

9. [Acute promyelocytic leukemia with STAT3-RARα fusion gene: a case report and literatures review].

Review 10. Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.

Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t(15;17)(q22;q12)/PML-RARA.

1. Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions.

Review 2. Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

3. Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.

4. Arsenic trioxide induces proteasome dependent TBLR1-RARα degradation to improve leukemia eradication through cell differentiation enhancement.

5. RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin-proteasome pathway contributes to the reversion of ATRA resistance.

6. A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review.

Review 7. PLZF-RARα, NPM1-RARα, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.

Review 8. Classic and Variants APLs, as Viewed from a Therapy Response.

9. [Acute promyelocytic leukemia with STAT3-RARα fusion gene: a case report and literatures review].

Review 10. Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.

Review 7. PLZF-RAR_α, NPM1-RAR_α, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.